| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.26 | 0.002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |